Does transforming growth factor-β1 predict for radiation-induced pneumonitis in patients treated for lung cancer?

Elizabeth S. Evans, Zafer Kocak, Su Min Zhou, Daniel A. Kahn, Hong Huang, Donna R. Hollis, Kim L. Light, Mitchell S. Anscher, Lawrence B. Marks

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

The purpose of the study was to reassess the utility of transforming growth factor-beta-1 (TGF-β1) together with dosimetric and tumor parameters as a predictor for radiation pneumonitis (RP). Of the 121 patients studied, 32 (26.4%) developed grade ≥ 1 RP, and 27 (22.3%) developed grade ≥ 2 RP. For the endpoint of grade ≥ 1 RP, those with V30 > 30% and an end-RT/baseline TGF-β1 ratio ≥ 1 had a significantly higher incidence of RP than did those with V30 > 30% and an end-RT/baseline TGF-β1 ratio < 1. For most other patient groups, there were no clear associations between TGF-β1 values and rates of RP. These findings suggest that TGF-β1 is generally not predictive for RP except for the group of patients with a high V30.

Original languageEnglish (US)
Pages (from-to)186-192
Number of pages7
JournalCytokine
Volume35
Issue number3-4
DOIs
StatePublished - Aug 1 2006

Fingerprint

Radiation Pneumonitis
Transforming Growth Factors
Lung Neoplasms
Transforming Growth Factor beta
Radiation
Tumors
Incidence

Keywords

  • Radiation pneumonitis
  • TGF-β1

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Biochemistry
  • Hematology
  • Molecular Biology

Cite this

Does transforming growth factor-β1 predict for radiation-induced pneumonitis in patients treated for lung cancer? / Evans, Elizabeth S.; Kocak, Zafer; Zhou, Su Min; Kahn, Daniel A.; Huang, Hong; Hollis, Donna R.; Light, Kim L.; Anscher, Mitchell S.; Marks, Lawrence B.

In: Cytokine, Vol. 35, No. 3-4, 01.08.2006, p. 186-192.

Research output: Contribution to journalArticle

Evans, ES, Kocak, Z, Zhou, SM, Kahn, DA, Huang, H, Hollis, DR, Light, KL, Anscher, MS & Marks, LB 2006, 'Does transforming growth factor-β1 predict for radiation-induced pneumonitis in patients treated for lung cancer?', Cytokine, vol. 35, no. 3-4, pp. 186-192. https://doi.org/10.1016/j.cyto.2006.07.021
Evans, Elizabeth S. ; Kocak, Zafer ; Zhou, Su Min ; Kahn, Daniel A. ; Huang, Hong ; Hollis, Donna R. ; Light, Kim L. ; Anscher, Mitchell S. ; Marks, Lawrence B. / Does transforming growth factor-β1 predict for radiation-induced pneumonitis in patients treated for lung cancer?. In: Cytokine. 2006 ; Vol. 35, No. 3-4. pp. 186-192.
@article{31bed943f16544a0b999f21ea6cbae2d,
title = "Does transforming growth factor-β1 predict for radiation-induced pneumonitis in patients treated for lung cancer?",
abstract = "The purpose of the study was to reassess the utility of transforming growth factor-beta-1 (TGF-β1) together with dosimetric and tumor parameters as a predictor for radiation pneumonitis (RP). Of the 121 patients studied, 32 (26.4{\%}) developed grade ≥ 1 RP, and 27 (22.3{\%}) developed grade ≥ 2 RP. For the endpoint of grade ≥ 1 RP, those with V30 > 30{\%} and an end-RT/baseline TGF-β1 ratio ≥ 1 had a significantly higher incidence of RP than did those with V30 > 30{\%} and an end-RT/baseline TGF-β1 ratio < 1. For most other patient groups, there were no clear associations between TGF-β1 values and rates of RP. These findings suggest that TGF-β1 is generally not predictive for RP except for the group of patients with a high V30.",
keywords = "Radiation pneumonitis, TGF-β1",
author = "Evans, {Elizabeth S.} and Zafer Kocak and Zhou, {Su Min} and Kahn, {Daniel A.} and Hong Huang and Hollis, {Donna R.} and Light, {Kim L.} and Anscher, {Mitchell S.} and Marks, {Lawrence B.}",
year = "2006",
month = "8",
day = "1",
doi = "10.1016/j.cyto.2006.07.021",
language = "English (US)",
volume = "35",
pages = "186--192",
journal = "Cytokine",
issn = "1043-4666",
publisher = "Academic Press Inc.",
number = "3-4",

}

TY - JOUR

T1 - Does transforming growth factor-β1 predict for radiation-induced pneumonitis in patients treated for lung cancer?

AU - Evans, Elizabeth S.

AU - Kocak, Zafer

AU - Zhou, Su Min

AU - Kahn, Daniel A.

AU - Huang, Hong

AU - Hollis, Donna R.

AU - Light, Kim L.

AU - Anscher, Mitchell S.

AU - Marks, Lawrence B.

PY - 2006/8/1

Y1 - 2006/8/1

N2 - The purpose of the study was to reassess the utility of transforming growth factor-beta-1 (TGF-β1) together with dosimetric and tumor parameters as a predictor for radiation pneumonitis (RP). Of the 121 patients studied, 32 (26.4%) developed grade ≥ 1 RP, and 27 (22.3%) developed grade ≥ 2 RP. For the endpoint of grade ≥ 1 RP, those with V30 > 30% and an end-RT/baseline TGF-β1 ratio ≥ 1 had a significantly higher incidence of RP than did those with V30 > 30% and an end-RT/baseline TGF-β1 ratio < 1. For most other patient groups, there were no clear associations between TGF-β1 values and rates of RP. These findings suggest that TGF-β1 is generally not predictive for RP except for the group of patients with a high V30.

AB - The purpose of the study was to reassess the utility of transforming growth factor-beta-1 (TGF-β1) together with dosimetric and tumor parameters as a predictor for radiation pneumonitis (RP). Of the 121 patients studied, 32 (26.4%) developed grade ≥ 1 RP, and 27 (22.3%) developed grade ≥ 2 RP. For the endpoint of grade ≥ 1 RP, those with V30 > 30% and an end-RT/baseline TGF-β1 ratio ≥ 1 had a significantly higher incidence of RP than did those with V30 > 30% and an end-RT/baseline TGF-β1 ratio < 1. For most other patient groups, there were no clear associations between TGF-β1 values and rates of RP. These findings suggest that TGF-β1 is generally not predictive for RP except for the group of patients with a high V30.

KW - Radiation pneumonitis

KW - TGF-β1

UR - http://www.scopus.com/inward/record.url?scp=33750526481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750526481&partnerID=8YFLogxK

U2 - 10.1016/j.cyto.2006.07.021

DO - 10.1016/j.cyto.2006.07.021

M3 - Article

C2 - 16979900

AN - SCOPUS:33750526481

VL - 35

SP - 186

EP - 192

JO - Cytokine

JF - Cytokine

SN - 1043-4666

IS - 3-4

ER -